Regeneron Pharmaceuticals, Inc. (REGN)


Stock Price Forecast

March 15, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Regeneron Pharmaceuticals, Inc. chart...

About the Company

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

$2B

Total Revenue

12K

Employees

$91B

Market Capitalization

27.61

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $REGN News

Buy Rating Affirmed for Regeneron on Eylea HD Success and Innovative Obesity Program

11h ago, source: Business Insider

Begin your TipRanks Premium journey today. Regeneron (REGN) Company Description: Founded in 1988, Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, develops, ...

Regeneron (REGN) Gets FDA Nod for Praluent Label Extension

6d ago, source: Zacks.com on MSN

Regeneron Pharmaceuticals, Inc. REGN announced that the FDA extended the approval of the cholesterol drug Praluent’s ...

Regeneron (REGN) to Report Q4 Earnings: What's in the Cards?

1mon ago, source: Hosted on MSN

Regeneron Pharmaceuticals, Inc.REGN is scheduled to release fourth-quarter 2023 results on Feb 2, before the opening bell. The company has an impressive track record, with an earnings beat in each ...

Regeneron Pharmaceuticals Inc REGN

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Is There An Opportunity With Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) 42% Undervaluation?

9d ago, source: Yahoo Finance

Using the 2 Stage Free Cash Flow to Equity, Regeneron Pharmaceuticals fair value estimate ... run through one way of ...

Regeneron Announces FDA Approval Extending Treatment Of Praluent To Children Aged 8

7d ago, source:

Regeneron Pharmaceuticals, Inc. (REGN) announced the FDA has extended the approval of Praluent as an adjunct to diet and other ...

Regeneron's Praluent injection gets FDA approval to treat kids with genetic form of high cholesterol

7d ago, source: Seeking Alpha on MSN

Regeneron Pharmaceuticals (NASDAQ:REGN) has received approval from the U.S. Food & Drug Administration (FDA) for its Praluent ...

Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

1mon ago, source: Stockhouse

A replay of the conference call and webcast will be archived on the Company's website for at least 30 days. About Regeneron Pharmaceuticals, Inc. Regeneron is a leading biotechnology company that ...

Regeneron Pharmaceuticals, Inc.: Praluent (alirocumab) Injection Receives FDA Approval to Treat Children with Genetic Form of High Cholesterol

8d ago, source:

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced the U.S. Food & Drug Administration (FDA) has extended the approval of Praluent® (alirocumab) ...

Regeneron Pharmaceuticals Inc REGN

3d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Regeneron's Praluent injection gets FDA approval to treat kids with genetic form of high cholesterol

7d ago, source: Seeking Alpha

Regeneron Pharmaceuticals (NASDAQ:REGN) has received approval from the U.S. Food & Drug Administration (FDA) for its Praluent (alirocumab) injection to treat children with genetic form of high ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...